Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium–glucose cotransporter 2 inhibitor

A 45-year-old woman was admitted for diabetic ketoacidosis (DKA). Aggressive rehydration and continuous intravenous insulin resulted in improved blood glucose levels; however, metabolic acidosis persisted. One day prior to admission, the patient took a single dose of a sodium–glucose cotransporter 2...

Full description

Saved in:
Bibliographic Details
Published inBMJ case reports Vol. 13; no. 10; p. e235969
Main Authors Miwa, Maki, Nakajima, Mikio, Kaszynski, Richard H, Goto, Hideaki
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 07.10.2020
BMJ Publishing Group
SeriesCase report
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 45-year-old woman was admitted for diabetic ketoacidosis (DKA). Aggressive rehydration and continuous intravenous insulin resulted in improved blood glucose levels; however, metabolic acidosis persisted. One day prior to admission, the patient took a single dose of a sodium–glucose cotransporter 2 (SGLT2) inhibitor and this likely contributed to the prolonged euglycemic DKA. A single dose of this drug remained effective for over 100 hours as evidenced by massive excretion of urine glucose continuing long after blood glucose normalisation. SGLT2 inhibitor use should be refrained in cases in which DKA has already occurred as they may result in increasing severity or prolonged DKA.
ISSN:1757-790X
1757-790X
DOI:10.1136/bcr-2020-235969